Reference ID: 3101735
Severe fluid retention occurred in 6.5% (6/92) of patients despite use of a 3-day dexamethasone premedication regimen. It was characterized by one or more of the following events: poorly tolerated peripheral edema, generalized edema, pleural effusion requiring urgent drainage, dyspnea at rest, cardiac tamponade, or
Download Reference ID: 3101735
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
EN-2890 Vancomycin Hydrochloride for Injection, …
www.accessdata.fda.govbacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed.
Related documents
Cornell Health Laxative Use: What to Know
health.cornell.eduinclude fluid retention, constipation, bloating, and temporary weight gain (from water and stool). Remember that in the long run your symptoms will improve, and you will be much healthier and feel better when you are not taking laxatives. Keeping “regular” To prevent constipation and avoid using . laxatives: • Be sure to include at least ...
Fluid, Electrolyte, and Acid-Base Balance
mymission.lamission.eduFluid balance refers to the proper levels of water and electrolytes being in the various body compartments according to their needs. ... retention (due to hypoventilation), which can result in the accumulation of carbonic acid and thus a fall in blood pH to below normal.
NANDA LIST OF DIAGNOSIS - uCoz
nclex.ucoz.netUrinary retention, (acute/chronic) Food/Fluid . Breastfeeding, effective . Breastfeeding, ineffective . Breastfeeding, interrupted . Fluid volume deficit (active loss) Fluid volume deficit (regulatory failure) Fluid volume deficit, risk for . Fluid volume excess . Infant feeding pattern, ineffective . Nutrition: altered, less than body requirements
HIGHLIGHTS OF PRESCRIBING INFORMATION Cardiovascular ...
packageinserts.bms.com• Fluid Retention: Fluid retention, sometimes severe, including pleural effusions. Manage with supportive care measures and/or dose modification. (2.5, 5.3) • Cardiovascular Toxicity Monitor patients for signs or symptoms and treat : appropriately. (5.4) • Pulmonary Arterial Hypertension (PAH): SPRYCEL (dasatinib) may increase the
GUIDELINES Intravenous fluid therapy for adults in ...
www.bmj.comPostoperative fluid retention and redistribution Malnourished and refeeding issues Seek expert help if necessary and estimate requirements Ongoing abnormal fluid or electrolyte losses Check ongoing losses and estimate amounts Check for: Vomiting and NG tube loss Biliary drainage loss High or low volume ileal stoma loss Diarrhoea or excess ...
ABDOMINAL BLOATING: A MYSTERIOUS SYMPTOM
www.med.unc.edudisorders. Several different causes of bloating have been suggested (malabsorption of sugars, fluid retention, etc), and more research is needed to determine whether these are distinct types of bloating that may require different treatments. Treatment includes avoiding offending food and
edema. enfoque clínico Baldomero Flores-Villegas, 1 Ivan ...
www.medigraphic.comretention of water and sodium. Edema secondary to exudates is due to increased in the blood vessel perme-ability to the blood proteins (e.g. during infecction), or secondary to lymphatic tissue obstruction (e.g. neoplasias) causing localized edema in the involved body part. Edema can be related to drugs (e.g. calcium
nursing services Dressings and wound management
www.rch.org.auIf the foam is non-adhesive the dressing can be held in place with tape, netting, tubular retention bandage or undercast padding: • If exudate levels are high this can cause the surrounding skin to macerate. To prevent this, skin preparation creams or protective barrier films may aid in protecting the surrounding skin.